TACHEM
Latest round
- Series A
Last raised
- Nov 2023
Total raised
- $42M
Investors
- 8
About TACHEM
Established in 2013 and based in Chengdu, China, TACHEM is a biotechnology enterprise engaged in the research, development, production, and sales of protected amino acid series products. The company is headquartered in Chengdu, and established a wholly-owned subsidiary in Lanzhou in 2020, with three standardized plants of more than 1,000 square meters, with an annual output of more than 200 tons, for use as a production base. It has passed the certification of ISO9001:2015 Quality Management System, and was certified as a Specialized and Innovative Small and Medium-sized Enterprises in Sichuan Province in 2022. The company mainly produces chemical raw materials, and currently possesses the production technology of more than 1,000 protected amino acids and non-natural amino acid series products and is capable of industrialized production, the specific products include Fmoc-Ala-OH-H2O, Fmoc-Aib-OH, fragment peptide series, and amino acid (linker) resins and so on. The company also possesses preparative chromatography as well as reactors of different sizes ranging from 50L to 5000L and other related equipments, which allow it to make customized products in various batches according to customers' needs, including customized synthesis of various impurities.
Who invested in TACHEM
8 investors across 1 round
See all investors in TACHEM
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 29, 2023
Amount
$42M
Investors
Questions about TACHEM
Who invested in TACHEM?
TACHEM has 8 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TACHEM raised?
TACHEM has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did TACHEM last raise money?
TACHEM's most recent round on record is a Series A, in Nov 2023.
What does TACHEM do?
Established in 2013 and based in Chengdu, China, TACHEM is a biotechnology enterprise engaged in the research, development, production, and sales of protected amino acid series products.
Where is TACHEM headquartered?
TACHEM is headquartered in Chengdu, China.
Which VCs invest in companies like TACHEM?
Among active investors with capital left to deploy, Hui Hua Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back materials companies at TACHEM's stage. Their profiles are linked below.
VCs backing materials startups at Series A
Raising like TACHEM? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.